Preliminary Evidence Supports Benefit of Urinary-Derived hCG in Acute GVHD
In this phase I clinical trial, 2 different cohorts of patients with acute GVHD received subcutaneous injections of uhCG along with standard-of-care treatment.
Hematologic Cancers
Hematologic Cancers News & Features
Prognostic Value of Immunomodulator in Higher-Risk Myelodysplastic Syndromes Treated With Azacitidine
Immunomodulator indoleamine-2,3-dioxygenase may be a promising predictor and therapeutic target for patients with higher-risk myelodysplastic syndromes.
Depression/Antidepressant Use Associated With QOL but not OS in Patients With Hematologic Malignancies Undergoing HSCT, Study Finds
This study separately evaluated the impact of depression/antidepressant use on the QOL and OS of cohorts of patients undergoing allogeneic or autologous HSCT.
Nivolumab Plus AVD Found Highly Effective in Early-Stage Unfavorable cHL
First-line treatment of early-stage, unfavorable classic Hodgkin lymphoma with nivolumab plus doxorubicin, vinblastine, and dacarbazine resulted in high response rates and PFS in a phase 2 study.
Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
